Want to see FR:XFAB full AI Analyst Report?
Top Page
X-Fab Silicon Foundries SE
(XFAB)
Select Model
Select Model
Rating:43Neutral
Price Target:
€5.50
▼(-12.14% Downside)
Action:Reiterated
Date:10/30/26
Overall score is weighed down primarily by weakening financial performance (margin compression, TTM net loss, and structurally negative free cash flow). Technicals add pressure with the stock trading below key moving averages and negative MACD. Valuation further detracts due to a very high P/E and no dividend yield provided.
Positive Factors
Specialty foundry positioning
XFAB’s specialty analog and mixed-signal focus serves multiple established end markets rather than relying on one narrow application. This positioning can support durable customer relevance and differentiation where process expertise, qualification and reliable manufacturing matter over several quarters.
Negative Factors
Revenue and gross-margin deterioration
Lower revenue combined with a sharp gross-margin contraction indicates meaningful pressure on demand, pricing or production economics. If this persists, it can reduce the earnings contribution from each wafer and make recovery more dependent on stronger utilization or cost improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialty foundry positioning
XFAB’s specialty analog and mixed-signal focus serves multiple established end markets rather than relying on one narrow application. This positioning can support durable customer relevance and differentiation where process expertise, qualification and reliable manufacturing matter over several quarters.
Read all positive factors
X-Fab Silicon Foundries SE (XFAB) vs. iShares MSCI France ETF (EWQ)
Market Cap
€726.31M
Dividend YieldN/A
Average Volume (3M)342.22K
Price to Earnings (P/E)154.3
Beta (1Y)1.09
Revenue Growth-3.09%
EPS Growth-86.76%
CountryFR
Employees4,300
SectorTechnology
Sector Strength88
IndustrySemiconductors
Share Statistics
EPS (TTM)-0.11
Shares Outstanding130,781,680
10 Day Avg. Volume369,254
30 Day Avg. Volume342,224
Financial Highlights & Ratios
PEG Ratio-0.52
Price to Book (P/B)0.75
Price to Sales (P/S)0.88
P/FCF Ratio-9.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€9.40Price Target Upside50.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.03
Revenue Forecast (FY)€814.39M
X-Fab Silicon Foundries SE Business Overview & Revenue Model
Company Description
X-FAB Silicon Foundries SE functions as a specialist foundry, providing manufacturing services for analog and mixed-signal semiconductor technologies. The company is involved in the fabrication of silicon wafers, which serve a broad spectrum of in...
X-Fab Silicon Foundries SE Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
63
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 808.85M | 905.74M | 816.38M | 906.79M | 739.47M | 657.75M |
| Gross Profit | 133.94M | 191.92M | 182.95M | 258.05M | 175.95M | 149.98M |
| EBITDA | 159.03M | 241.01M | 224.93M | 256.19M | 167.79M | 150.55M |
| Net Income | -14.76M | 31.36M | 61.52M | 161.90M | 52.49M | 83.61M |
Balance Sheet | ||||||
| Total Assets | 1.86B | 1.95B | 1.90B | 1.70B | 1.26B | 986.93M |
| Cash, Cash Equivalents and Short-Term Investments | 192.79M | 194.34M | 215.84M | 406.24M | 369.43M | 290.19M |
| Total Debt | 503.03M | 480.46M | 414.13M | 260.98M | 296.94M | 127.03M |
| Total Liabilities | 835.38M | 893.79M | 876.66M | 743.27M | 458.09M | 242.59M |
| Stockholders Equity | 1.02B | 1.05B | 1.02B | 960.54M | 796.97M | 743.97M |
Cash Flow | ||||||
| Free Cash Flow | -52.20M | -79.43M | -313.50M | 72.17M | -80.59M | 42.54M |
| Operating Cash Flow | 53.48M | 133.02M | 196.05M | 409.96M | 99.99M | 109.51M |
| Investing Cash Flow | -88.14M | -210.80M | -496.13M | -323.62M | -174.98M | -65.15M |
| Financing Cash Flow | 60.83M | 47.04M | 116.30M | -53.16M | 158.03M | 48.23M |
X-Fab Silicon Foundries SE Technical Analysis
Negative
6.26
Price Trends
6.06
Negative
6.85
Negative
6.49
Negative
Market Momentum
-0.28
Positive
44.02
Neutral
67.75
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:XFAB, the sentiment is Negative. The current price of 6.26 is above the 20-day moving average (MA) of 5.79, above the 50-day MA of 6.06, and below the 200-day MA of 6.49, indicating a bearish trend. The MACD of -0.28 indicates Positive momentum. The RSI at 44.02 is Neutral, neither overbought nor oversold. The STOCH value of 67.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:XFAB.
X-Fab Silicon Foundries SE Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | €139.49M | 22.88 | 23.75% | 1.51% | 11.11% | 99.40% | |
56 Neutral | €38.48M | 35.46 | 5.66% | 1.32% | 10.87% | 46.41% | |
53 Neutral | €4.76B | -21.56 | -15.71% | ― | -33.51% | -339.49% | |
43 Neutral | €726.31M | 154.32 | 0.45% | ― | -3.09% | -86.76% | |
43 Neutral | €13.45M | -6.88 | -69.65% | ― | ― | ― | |
43 Neutral | €70.60M | -27.32 | -4.60% | ― | -21.71% | 91.06% |
* Technology Sector Average
FR:XFAB
X-Fab Silicon Foundries SE
5.56
-0.93
-14.33%
FR:ALGID
Egide SA
0.68
0.24
54.55%
FR:SOI
Soitec SA
133.00
91.23
218.41%
FR:MEMS
MEMSCAP SA
5.00
0.91
22.19%
FR:ALRIB
Riber SA
6.63
3.38
104.06%
FR:ALKAL
Kalray SA
3.82
2.77
263.81%
X-Fab Silicon Foundries SE Corporate Events
X-FAB Balances Auto Slowdown With Data Center Push and Medical Growth
Jul 30, 2026
X-FAB reported second-quarter 2026 revenue of 199.8 million USD, down 7% year-on-year but 2% higher than the previous quarter, with core automotive, industrial and medical sales totaling 182.1 million USD. EBITDA fell 35% to 33.6 million USD and E...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.